MarcusBosenbergMDPhD

Dermatopathology, Anatomic Pathology, Clinical Pathology

Professor of Dermatology and Pathology Yale University

Dr. Bosenberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
15 York Street
New Haven, CT 06520
Phone+1 203-737-3484

Fax+1 203-785-6869

Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Dermatopathology, 1999 - 2000
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1996 - 1999
Weill Cornell MedicineClass of 1994

PubMed

Setdb1 Loss Induces Type I Interferons and Immune Clearance of Melanoma.
Meaghan K McGeary, William Damsky, Andrew J Daniels, Sabine M Lang, Qingji Xu
Cancer Immunology Research. 2025-02-03
Scavenger Receptor CD36 in Tumor-Associated Macrophages Promotes Cancer Progression by Dampening Type-I IFN Signaling.
Ziyan Xu, Alexandra Kuhlmann-Hogan, Shihao Xu, Hubert Tseng, Dan Chen
Cancer Research. 2025-02-01
DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.
Kathleen Conway, Sharon N Edmiston, Amanda Vondras, Allison Reiner, David L Corcoran
JCO Precision Oncology. 2024-11-01

Journal Articles

Autophagy Maintains Tumour Growth Through Circulating Arginine
Janice M Mehnert, Marcus W Bosenberg, Nature
PD‐L1 Methylation Regulates PD‐L1 Expression and Is Associated with Melanoma Survival
Goran Micevic, Marcus Bosenberg, Durga Thakral, Pigment Cell & Melanoma Research

Yale Cancer Center Study Shows New Strategy to Boost Immune System to Fight MelanomaOctober 19th, 2021
Scientists Identify Gene That Regulates Growth of MelanomaFebruary 29th, 2016
Melanoma and Papillary Thyroid Cancer: Shared Environmental Risk?February 10th, 2016
Join now to see all